{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T10:04:13Z","timestamp":1785578653434,"version":"3.56.0"},"reference-count":39,"publisher":"Cambridge University Press (CUP)","issue":"4","license":[{"start":{"date-parts":[[2016,9,14]],"date-time":"2016-09-14T00:00:00Z","timestamp":1473811200000},"content-version":"unspecified","delay-in-days":257,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Technol Assess Health Care"],"published-print":{"date-parts":[[2016]]},"abstract":"<jats:p><jats:bold>Objectives:<\/jats:bold>Herpes zoster (HZ) is characterized by a painful skin rash. Its main complication is postherpetic neuralgia (PHN), pain persisting or occurring after the rash onset. HZ treatment aims to reduce acute pain, impede the onset complications, and disease progression. The aim of this study was to assess the cost-effectiveness of HZ vaccination compared with no vaccination strategy, within the Italian context.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold>The natural history of HZ and PHN was mapped through a Markov model with lifetime horizon. A population of patients aged between 60 and 79 years was hypothesized. Third party payer (Italian National Health Service, I-NHS) and societal perspectives were adopted. Data were derived from literature.<\/jats:p><jats:p><jats:bold>Results and Conclusions:<\/jats:bold>The incremental cost-effectiveness ratio of the vaccination equaled EUR 11,943 per quality-adjusted life-year (QALY) under the I-NHS perspective and EUR 11,248 per QALY under the societal perspective. Considering a cost-effectiveness threshold of EUR 30,000\/QALY, the multi-way sensitivity analysis showed that vaccination is cost-effective regardless of the perspective adopted, in 99 percent of simulations.<\/jats:p>","DOI":"10.1017\/s0266462316000337","type":"journal-article","created":{"date-parts":[[2016,9,14]],"date-time":"2016-09-14T04:27:20Z","timestamp":1473827240000},"page":"233-240","source":"Crossref","is-referenced-by-count":10,"title":["COST-EFFECTIVENESS ANALYSIS OF HERPES ZOSTER VACCINATION IN ITALIAN ELDERLY PERSONS"],"prefix":"10.1017","volume":"32","author":[{"given":"Silvia","family":"Coretti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Codella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5455-7352","authenticated-orcid":false,"given":"Federica","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Ruggeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Americo","family":"Cicchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2016,9,14]]},"reference":[{"key":"S0266462316000337_ref037","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.01.058"},{"key":"S0266462316000337_ref018","doi-asserted-by":"publisher","DOI":"10.1086\/514342"},{"key":"S0266462316000337_ref032","unstructured":"Indicatori del lavoro nelle imprese. Available at: www.istat.it (accessed September 16, 2014)."},{"key":"S0266462316000337_ref024","unstructured":"Italian Agency of Medicines. Database of authorized medicines. Online source. Available at: https:\/\/farmaci.agenziafarmaco.gov.it\/bancadatifarmaci\/cerca-farmaco (accessed August 2016)."},{"key":"S0266462316000337_ref021","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-8-272"},{"key":"S0266462316000337_ref023","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(98)00036-5"},{"key":"S0266462316000337_ref009","doi-asserted-by":"publisher","DOI":"10.1186\/1478-7547-8-7"},{"key":"S0266462316000337_ref006","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/19.5.471"},{"key":"S0266462316000337_ref012","doi-asserted-by":"publisher","DOI":"10.1016\/S1201-9712(07)60021-6"},{"key":"S0266462316000337_ref034","doi-asserted-by":"publisher","DOI":"10.1017\/S1744133106004026"},{"key":"S0266462316000337_ref005","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051016"},{"key":"S0266462316000337_ref022","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2005.01.359"},{"key":"S0266462316000337_ref017","doi-asserted-by":"crossref","unstructured":"Bricout H , Perinetti E , Marchettini P , et al. Predictive factors for the presence of post herpetic neuralgia at 3 months in herpes zoster patients aged 50 and over in Italy: Results from a gp-based observational prospective multicenter study. ISPOR 16th Annual EU Conference Dublin, Ireland, November 3\u20136, 2013.","DOI":"10.1016\/j.jval.2013.08.124"},{"key":"S0266462316000337_ref007","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.10316"},{"key":"S0266462316000337_ref011","doi-asserted-by":"publisher","DOI":"10.4161\/hv.7.7.15573"},{"key":"S0266462316000337_ref015","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.21254"},{"key":"S0266462316000337_ref003","doi-asserted-by":"publisher","DOI":"10.1586\/17469872.1.4.607"},{"key":"S0266462316000337_ref031","unstructured":"Ministero della Salute. National Health Care Range of Fees for specialist outpatient visits updated by Ministerial Decree dated October 18th, 2012. Available at: http:\/\/www.trovanorme.salute.gov.it\/norme\/renderpdf (accessed July 2014)."},{"key":"S0266462316000337_ref036","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.298.6671.431"},{"key":"S0266462316000337_ref033","doi-asserted-by":"publisher","DOI":"10.1016\/j.respe.2010.06.166"},{"key":"S0266462316000337_ref004","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-10-230"},{"key":"S0266462316000337_ref028","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200422130-00003"},{"key":"S0266462316000337_ref014","first-page":"275","article-title":"Clinical and psychosocial correlates of acute pain in herpes zoster","volume":"38","author":"Volpi","year":"2007","journal-title":"J Med Virol."},{"key":"S0266462316000337_ref038","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001420"},{"key":"S0266462316000337_ref020","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.09.066"},{"key":"S0266462316000337_ref026","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2011-000736"},{"key":"S0266462316000337_ref019","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir970"},{"key":"S0266462316000337_ref035","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-6296(96)00506-1"},{"key":"S0266462316000337_ref027","doi-asserted-by":"publisher","DOI":"10.1185\/030079907X242610"},{"key":"S0266462316000337_ref030","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.07.049"},{"key":"S0266462316000337_ref029","first-page":"1","article-title":"Evaluation of the economic burden of Herpes Zoster (HZ) infection","volume":"11","author":"Panatto","year":"2014","journal-title":"A systematic literature review. Hum Vaccin Immunother."},{"key":"S0266462316000337_ref001","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMct066061"},{"key":"S0266462316000337_ref010","doi-asserted-by":"publisher","DOI":"10.3111\/13696998.2010.502854"},{"key":"S0266462316000337_ref002","first-page":"571","volume":"25","author":"neuralgia","year":"1975","journal-title":"J R Coll Gen Pract."},{"key":"S0266462316000337_ref013","unstructured":"ISTAT. Available at: http:\/\/www.istat.it (accessed July 25, 2016)."},{"key":"S0266462316000337_ref025","unstructured":"Italian Agency of Medicines. Regime di rimborsabilit\u00e0 e prezzo di vendita del medicinale \u00abZostavax\u00bb (vaccino dello Zoster (vivo)), autorizzata con procedura centralizzata europea dalla Commissione europea. (Determinazione\/C 371\/2010). Online source. Available at: http:\/\/www.gazzettaufficiale.it\/do\/atto\/serie_generale\/caricaPdf?cdimg=10A0490400000010110012&dgu=2010-04-29&art.dataPubblicazioneGazzetta=2010-04-29&art.codiceRedazionale=10A04904&art.num=1&art.tiposerie=SG (accessed August 2016)."},{"key":"S0266462316000337_ref008","doi-asserted-by":"publisher","DOI":"10.1586\/erp.13.19"},{"key":"S0266462316000337_ref016","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2006.09.021"},{"key":"S0266462316000337_ref039","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.1983"}],"container-title":["International Journal of Technology Assessment in Health Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0266462316000337","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T09:16:39Z","timestamp":1568366199000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0266462316000337\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016]]}},"alternative-id":["S0266462316000337"],"URL":"https:\/\/doi.org\/10.1017\/s0266462316000337","relation":{},"ISSN":["0266-4623","1471-6348"],"issn-type":[{"value":"0266-4623","type":"print"},{"value":"1471-6348","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}